ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Total income | 0.0 | 0.0 | 0.0 |
| Profit before exceptional items & tax | -0.0 | -0.0 | -0.0 |
| Profit before tax | -0.0 | -0.0 | -0.0 |
| Net profit | -0.0 | -0.0 | -0.0 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: TRABI. Figures extracted from the filing.
Transgene Biotek Ltd: key numbers
- Share price
- ₹2.55
- Market cap
- ₹19.32 Cr
- Revenue (annual)
- ₹0.21 Cr
- Net profit (annual)
- ₹-1.65 Cr
- P/E (TTM)
- -12.0×Sector 54.7×
- Promoter holding
- 23.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Transgene Biotek Ltd
All →Transgene Biotek Annual General Meeting
Transgene Biotek closed its register of members from December 24 to 30, 2026 for its 36th AGM. The e-voting cut-off date is December 23, 2026.
Transgene Biotek Management Change
Transgene Biotech re-appointed K. Koteswara Rao as Managing Director for 12 months. The board resolution dated November 13, 2026 confirms continued KMP leadership.
Transgene Biotek Board Meeting Date
Transgene Biotek will hold a board meeting on 13 November 2026 to consider quarterly results, AGM notice, and other matters. The agenda is proposed only, and no outcomes have been approved yet.
Transgene Biotek Other Announcement
Transgene Biotech appointed M/s. Harish Gummadi & Co as Statutory Auditor for a two-month term effective 2 November 2026. The appointment was approved at the board meeting on the same date.
- Execution
- 2 months
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Transgene Biotek Board Meeting Outcome
Transgene Biotek Limited appointed M/s. Eswara Rao & Co. as the new statutory auditor to fill a casual vacancy, subject to shareholder approval.